» Articles » PMID: 11996690

Outbreak of Neisseria Meningitidis, Edmonton, Alberta, Canada

Overview
Date 2002 May 9
PMID 11996690
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

From December 1999 to April 2001, the greater Edmonton region had 61 cases of invasive meningococcal infection, two fatal. The outbreak was due to Neisseria meningitidis serogroup C, electrophoretic type 15, serotype 2a. Analysis of the strains showed that 50 of 56 culture-confirmed cases were due to a single clone and close relatives of this clone. This strain had not been previously identified in the province of Alberta dating back to January 1997.

Citing Articles

Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.

Soumahoro L, Abitbol V, Vicic N, Bekkat-Berkani R, Safadi M Infect Dis Ther. 2021; 10(4):1949-1988.

PMID: 34379309 PMC: 8572905. DOI: 10.1007/s40121-021-00499-3.


Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story.

De Wals P Can J Infect Dis Med Microbiol. 2019; 2019:8901847.

PMID: 31885753 PMC: 6899262. DOI: 10.1155/2019/8901847.


Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

van Kessel F, van den Ende C, Oordt-Speets A, Kyaw M J Glob Health. 2019; 9(1):010411.

PMID: 30937163 PMC: 6441124. DOI: 10.7189/jogh.09.010411.


A decade of invasive meningococcal disease surveillance in Poland.

Skoczynska A, Wasko I, Kuch A, Kadlubowski M, Golebiewska A, Forys M PLoS One. 2013; 8(8):e71943.

PMID: 23977184 PMC: 3748050. DOI: 10.1371/journal.pone.0071943.


The changing epidemiology of meningococcal disease in North America 1945-2010.

Baccarini C, Ternouth A, Wieffer H, Vyse A Hum Vaccin Immunother. 2012; 9(1):162-71.

PMID: 23108355 PMC: 3667932. DOI: 10.4161/hv.22302.


References
1.
Ashton F, Ryan J, Borczyk A, Caugant D, Mancino L, Huang D . Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol. 1991; 29(11):2489-93. PMC: 270360. DOI: 10.1128/jcm.29.11.2489-2493.1991. View

2.
Ashton F, Ryan A, DIENA B . Improved antiserum agar method for the serogroup differentiation of Neisseria meningitidis Y and W135. Can J Microbiol. 1980; 26(5):630-2. DOI: 10.1139/m80-109. View

3.
Craven D, Frasch C . Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol. 1979; 9(4):547-8. PMC: 273073. DOI: 10.1128/jcm.9.4.547-548.1979. View

4.
Squires S, Pelletier L, Mungai M, Tsang R, Collins F, Stoltz J . Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998. Can Commun Dis Rep. 2000; 26(21):177-82. View

5.
Tikhomirov E . Meningococcal meningitis: global situation and control measures. World Health Stat Q. 1987; 40(2):98-109. View